What medications are effective for treating hyperactivity in ADHD?

PostedAugust 22, 2025

UpdatedSeptember 5, 2025

ByMy Patient Advice

Author: Victoria Rowe, MSc | Reviewed by: Dr. Rebecca Fernandez, MBBS

Medication is often a key part of ADHD treatment, helping to manage hyperactivity, impulsivity, and inattention. Clinicians use evidence-based ADHD drugs that target brain chemistry to improve focus and self-control, offering individuals better hyperactivity control.

The most prescribed medications fall into two main categories: stimulant medication and non-stimulant options. Stimulants work quickly and effectively for most people, while non-stimulants may suit those who experience side effects or have other health considerations. The choice of treatment is highly individual and made with careful medical supervision.

Common Medications for Hyperactivity

Here are the main types of medications used in ADHD treatment, along with how they help manage symptoms:

Stimulant Medication (e.g., Methylphenidate, Amphetamines)

These are the first-line treatments for ADHD. They boost dopamine and norepinephrine in the brain, improving focus and reducing impulsivity(1) They can help individuals remain seated, pay attention, and complete tasks more efficiently.

Non-Stimulant Medication (e.g., Atomoxetine, Guanfacine)

These are useful for people who do not tolerate stimulants or have co-occurring conditions. They act on different neurotransmitter systems, offering more gradual improvements in hyperactivity control.

Adjunctive Medications

Sometimes antidepressants or mood stabilisers are used alongside ADHD drugs to manage additional symptoms such as anxiety or aggression.

Choosing the right medication often involves trial and adjustment, guided by a knowledgeable clinician. Visit providers like ADHD Certify for personal consultations and expert advice on your options.

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Hyperactivity.

Victoria Rowe, MSc

Author

Victoria Rowe is a health psychologist with a Master’s in Health Psychology and a BS in Applied Psychology. She has experience as a school psychologist, conducting behavioural assessments, developing individualized education plans (IEPs), and supporting children’s mental health. Dr. Rowe has contributed to peer-reviewed research on mental health, including studies on anxiety disorders and the impact of COVID-19 on healthcare systems. Skilled in SPSS, Minitab, and academic writing, she is committed to advancing psychological knowledge and promoting well-being through evidence-based practice.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.

Dr. Rebecca Fernandez, MBBS

Reviewer

Dr. Rebecca Fernandez is a UK-trained physician with an MBBS and experience in general surgery, cardiology, internal medicine, gynecology, intensive care, and emergency medicine. She has managed critically ill patients, stabilised acute trauma cases, and provided comprehensive inpatient and outpatient care. In psychiatry, Dr. Fernandez has worked with psychotic, mood, anxiety, and substance use disorders, applying evidence-based approaches such as CBT, ACT, and mindfulness-based therapies. Her skills span patient assessment, treatment planning, and the integration of digital health solutions to support mental well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewer's privacy.